NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-187-2000-0-CA-05 A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses CA National Stage 2412050 Expired
NCI E-187-2000-0-AU-06 A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses AU National Stage 2001268452 Expired
NCI E-128-1992-0-AU-10 SPECIFIC TOLERANCE IN TRANSPLANTATION AU DIV 51964/01 Abandoned
NCI E-187-2000-0-PCT-02 A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses PCT PCT PCT/US2001/019201 Expired
NCI E-187-2000-0-JP-07 A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses JP National Stage 2002-510097 Abandoned
NCI E-187-2000-0-EP-04 A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses EP National Stage 01946395.9 Abandoned
NCI E-221-2001-0-US-01 PATE, A Gene Expressed in Prostate Cancer, Prostate And Testis, And Uses Thereof US 60/298,614 Abandoned
NIMH E-121-1995-1-US-03 SUSCEPTIBILITY GENES FOR BIPOLAR AFFECTIVE DISORDER US CON 09/881,012 6897022 Expired PDF
NIDDK E-133-2000-0-US-02 Rapid Fluorescenct Labeling of Tissue for Microdissection Using Fluorescent Specific Binding Agents US ORD 09/881,446 6790636 Abandoned PDF
CC E-176-2001-0-US-01 Compositions And Methods For Magnetically Labeling Cells US 60/298,209 Abandoned
NIMH E-079-2001-0-US-01 Use of The Parathyroid Hormone-2(PTH2) Receptor to Screen For Agents to Treat Pain US 60/297,959 Abandoned
NCI E-195-2001-0-JP-06 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury JP National Stage 2002-510114 Expired
NCI E-195-2001-0-CA-04 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury CA National Stage 2412501 Expired
NCI E-195-2001-0-NL-16 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury NL EP 01950301.0 Abandoned
NCI E-195-2001-0-EP-05 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury EP National Stage 01950301.0 Expired
NCI E-195-2001-0-IE-14 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury IE EP 01950301.0 Abandoned
NCI E-195-2001-0-IT-15 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury IT EP 01950301.0 Abandoned
NCI E-195-2001-0-CH-09 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury CH EP 01950301.0 Abandoned
NCI E-195-2001-0-GB-13 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury GB EP 01950301.0 Expired
NCI E-195-2001-0-DE-10 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury DE EP 01950301.0 Expired
NCI E-195-2001-0-FR-12 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury FR EP 01950301.0 Expired
NCI E-195-2001-0-ES-11 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury ES EP 01950301.0 Abandoned
NCI E-195-2001-0-AU-07 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury AU National Stage 2001271310 Expired
NCI E-195-2001-0-PCT-02 PHYTOESTROGENIC ISOFLAVONE COMPOSITIONS PCT PCT PCT/US2001/019089 Expired
NCI E-195-2001-1-PCT-02 Radioprotective Agents PCT PCT PCT/US2001/018772 Expired
NCI E-195-2001-0-EP-08 Phytoestrogenic Isoflavone Compositions, Their Preparation, And Use Thereof For Protection Against Treatment of Radiation Injury EP DIV 06024432.4 Abandoned
NHGRI E-273-1999-2-PCT-01 Method and System For Processing Regions of Interest For Objects Comprising Biological Material PCT PCT COMB PCT/US01/019176 Abandoned
NIBIB E-143-2000-0-DE-07 Sample Delivery System With Laminar Mixing for Microvolume BioSensing DE EP 01990651.0 Abandoned
NIBIB E-143-2000-0-FR-06 Sample Delivery System With Laminar Mixing for Microvolume BioSensing FR EP 01990651.0 Abandoned
NIBIB E-143-2000-0-GB-05 Sample Delivery System With Laminar Mixing for Microvolume BioSensing GB EP 01990651.0 Abandoned
NCI E-245-1994-0-US-08 CHIMERIC PAPILLOMA VIRUS-LIKE PARTICLES US CON 09/878,840 Abandoned
NCI E-216-2000-2-AU-06 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES AU National Stage 2001269762 Abandoned
NCI E-216-2000-2-IE-18 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES IE EP 01948294.2 Abandoned
NCI E-216-2000-2-ES-10 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES ES EP 01948294.2 Abandoned
NCI E-216-2000-2-CH-15 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES CH EP 01948294.2 Abandoned
NCI E-216-2000-2-SE-14 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES SE EP 01948294.2 Abandoned
NCI E-216-2000-2-IT-11 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES IT EP 01948294.2 Abandoned
NCI E-216-2000-2-DK-17 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES DK EP 01948294.2 Abandoned
NCI E-216-2000-2-BE-12 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES BE EP 01948294.2 Abandoned
NCI E-216-2000-2-AT-16 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES AT EP 01948294.2 Abandoned
NCI E-216-2000-2-EP-03 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES EP National Stage 01948294.2 Abandoned
NCI E-216-2000-2-NL-13 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES NL EP 01948294.2 Abandoned
NCI E-216-2000-2-GB-07 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES GB EP 01948294.2 Abandoned
NCI E-216-2000-2-DE-09 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES DE EP 01948294.2 Abandoned
NCI E-216-2000-2-FR-08 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES FR EP 01948294.2 Abandoned
NCI E-216-2000-2-PCT-01 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES PCT PCT COMB PCT/US2001/018503 Expired
NCI E-216-2000-2-JP-04 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES JP National Stage 2002-510119 Abandoned
NCI E-216-2000-2-CA-05 PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES CA National Stage 2411967 Abandoned
NINDS E-232-1999-0-US-02 Controlling Attention and Memory By Altering Neuronal Carbonic Anhydrase Activity US ORD 09/875,283 6552053 Abandoned PDF
NINDS E-232-1999-0-PCT-03 Controlling Attention and Memory By Altering Neuronal Carbonic Anhydrase Activity. PCT PCT PCT/US01/018329 Abandoned